HAL (France)open access
A new NRF2 activator for the treatment of human metabolic dysfunction-associated fatty liver disease
S217879, NRF2, NASH, Oxidative stress, Fibrosis, Inflammation, PCLS, MAFLD
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 274089
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.